A new WTW survey reveals that over half of employers exceeded their healthcare budgets in 2024 and expect rising costs to continue, prompting a shift toward cost-containment strategies, vendor ...
From left to right: Soumi Saha, senior vice president of government affairs at Premier Inc.; Jennifer Goldsack, founder and CEO of the Digital Medicine Society Hallucinations are a frequent point of ...
Pfizer’s internal obesity drug R&D stumbled, but the pharmaceutical giant is leaping ahead in this field through the multi-billion dollar acquisition of Metsera, a clinical-stage company whose ...
A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA approved, a regulatory decision that gives patients a less burdensome dosing option and provides the pharmaceutical ...
The U.S. Food & Drug Administration (FDA) recently removed its Risk Evaluation and Mitigation Strategies (REMS) designation from CAR T immunotherapies. REMS is occasionally applied to drugs with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback